Journal News Archive

:: CDC: COVID-19 vaccines recommended for young children - 2022/06/27 -
:: FDA Approves Risankizumab-rzaa for Moderately to Severely Active Crohn Disease - 2022/06/21 -
:: FDA Withdraws Umbralisib Due to Elevated Mortality Risk - 2022/06/6 -
:: Could some arthritis drugs reduce Alzheimer and related dementias risk in those with heart disease? - 2022/05/16 -
:: Cardiac Issues After COVID Infection and Vaccination: New Data - 2022/04/24 -
:: FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers - 2022/04/24 -
:: Pembrolizumab vs. placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma - 2022/04/5 -
:: Audio Interview: Effectiveness of Covid-19 Vaccination in Children - 2022/04/5 -
:: Compatibility of Commonly Used IV Drugs - 2022/02/20 -
:: FDA Delays Advisory Meeting for COVID-19 Vaccine for Very Young Kids - 2022/02/13 -
:: Omicron’s Differences, Sense of Smell, Effects on the Brain and Other News - 2022/02/13 -
:: FDA Limits Use of Monoclonal Antibodies to Treat COVID-19 - 2022/01/26 -
:: EHR Tool Flags Iron Deficiency In Heart Failure - 2022/01/16 -
:: Omicron wave: 9 in 10 pharmacies struggling with staff absences - 2022/01/16 -
:: No more annual flu shot? New target for universal influenza vaccine - 2022/01/8 -
:: Could vitamin D deficiency increase the risk of heart disease? - 2022/01/8 -
:: Immune Cell Population Potentially Responsible for Inflammation in Multiple Sclerosis - 2022/01/1 -
:: Coronavirus Can Spread to Heart, Brain Days After Infection - 2021/12/29 -
:: FDA Gives Nod to Tralokinumab for Adults With Moderate to Severe AD - 2021/12/29 -
:: Japan Health Panel Approves Merck's Oral COVID-19 Treatment - 2021/12/28 -
:: Positive Phase 3 Topline Results for Early Parkinson's Drug - 2021/12/28 -
:: Abrocitinib Approved for Atopic Dermatitis in Europe - 2021/12/14 -
:: Major COVID-19 Case Growth Expected in Coming Weeks - 2021/12/14 -
:: Feds Go on Offense Ahead of Potential Omicron Spread in US - 2021/12/5 -
:: New COVID Variant of Concern Drives US Travel Bans - 2021/11/27 -
:: Anticoagulants Can Ease Cognitive Decline in AF Patients - 2021/11/27 -
:: Pfizer Announces Agreement with US Government for COVID-19 Oral Antiviral Treatment - 2021/11/24 -
:: CDC Director Endorses Pfizer, Moderna Boosters for All US Adults - 2021/11/20 -
:: Stroke: Large study shows which types of fat and dietary sources lower risk - 2021/11/10 -
:: First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA - 2021/11/6 -
:: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5 to 11 - 2021/10/31 -
:: Using mRNA to Create the Elusive HIV Vaccine - 2021/10/26 -
:: High bioactivity proteins for antibody drug conjugate (ADC) development - 2021/10/19 -
:: FDA OKs New High-Dose Naloxone Product for Opioid Overdose - 2021/10/19 -
:: In Atopic Dermatitis Trial, Abrocitinib Offers Faster Itch Relief Than Dupilumab - 2021/10/6 -
:: First-in-Class TYK Inhibitor Shows Durable Effect for Psoriasis - 2021/10/2 -
:: Top Questions Answered About COVID Boosters for Your Patients - 2021/09/26 -
:: More older adults are taking drugs that can lead to falls - 2021/09/7 -
:: mRNA vaccines reduce risk of infection by 91% for fully vaccinated - 2021/09/7 -
:: Long COVID Symptoms Can Persist for More Than 1 Year, Study Shows - 2021/08/30 -
:: No Sequelae From Lab Abnormalities in Pediatric Isotretinoin Study - 2021/07/12 -
:: CDC and Pfizer at Odds Over Need for COVID-19 Booster Shots - 2021/07/12 -
:: Antibiotic Linked to Rise in Early-Onset Colon Cancer? - 2021/07/7 -
:: CDC recommends pregnant women get COVID-19 vaccine - 2021/06/30 -
:: EAS Lipid Guidance: Start High-risk Patients on Combo Drug - 2021/06/30 -
:: Cannabis could help manage symptoms of some neurological conditions - 2021/06/27 -
:: Long COVID’ needs to be addressed by multiple specialties - 2021/06/27 -
:: Researchers develop new therapeutic approach for treating acute myeloid leukemia - 2021/06/22 -
:: Moderna Applies for Full Approval for Its Vaccine - 2021/06/2 -
:: Novel Drug Approved by FDA for Some Bile Duct Cancers - 2021/06/2 -
:: COVID-19: More evidence that monoclonal antibodies reduce risk of death - 2021/05/22 -
:: Convalescent Plasma Flops for Hospitalized COVID Patients - 2021/05/19 -
:: Obesity: New drug turns ‘energy-storing’ fat into ‘energy-burning’ fat - 2021/05/18 -
:: COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety - 2020/12/28 -
:: Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial - 2020/11/14 -
:: International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy - 2020/11/14 -
:: Share your COVID experiences with 2 million+ researchers - 2020/09/30 -
:: From Brain to Behavior: The Search for Biomarkers - 2020/09/26 -
:: Happy Peer Review Week from ACS Publications - 2020/09/26 -
:: Hologic Showcased Latest Advances at Virtual ECR Congress 2020 - 2020/08/22 -
:: Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US - 2020/08/22 -
:: Upcoming Events of the ACSE - 2020/08/18 -
:: Introduction to testing for COVID-19 - 2020/08/9 -
:: Prospective randomized trial of interventions for vincristine-related neuropathic pain - 2020/07/18 -
:: COVID-19 resources: serological tests, face masks and benefits of physical activity - 2020/07/11 -
:: FDA approves generic albuterol inhaler to mitigate shortages during pandemic - 2020/07/8 -
:: What do we know for sure about hydroxychloroquine for COVID-19? Not much - 2020/07/8 -
:: Webinars for the Week of July 6th - 2020/07/8 -
:: COVID-19: Bacteriophage Could Decrease Mortality - 2020/06/29 -
:: Animal Models of COVID-19 - 2020/06/28 -
:: Social isolation can lead to depression in children long after current lockdown - 2020/06/28 -
:: Is COVID-19 Risk Linked to Blood Type? - 2010/07/1 -

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb